Carle Cancer Center NCI Community Oncology Research Progran (NCORP)

卡尔癌症中心 NCI 社区肿瘤​​学研究计划 (NCORP)

• 批准号: 8901101
• 负责人: KENDRITH Martin ROWLAND
• 金额: $ 80.1万
• 依托单位: CARLE FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8901101
• 关键词: Academia; Accounting; Address; Aftercare; Behavioral Research; Cancer Center; Caring; Cities; Clinical Trials; Collaborations; Communities; Community Clinical Oncology Program; Data; Data Quality; Development; Disease; Fostering; Funding; Goals; Health; Health system; Healthcare Systems; Illinois; Image; Indiana; Institution; Insurance; Intervention; Learning; Malignant Neoplasms; Medical center; Michigan; NCI Center for Cancer Research; Outcome; Patients; Physicians; Population; Prevention; Primary Health Care; Process; Protocols documentation; Quality of life; Recording of previous events; Research; Research Personnel; Resources; Rural; Rural Population; Services; Specimen; Surgeon; Translational Research; Underrepresented Minority; United States National Institutes of Health; Universities; Woman; anticancer research; base; cancer care; cancer prevention; cancer site; cancer therapy; care delivery; community setting; design; experience; improved; insight; interest; medical specialties; multidisciplinary; organizational structure; programs; response; screening; skills; treatment trial; tumor

DESCRIPTION (provided by applicant): In response to RFA-CA-13-013, the Carle Cancer Center, a 30 year legacy Community Clinical Oncology Program, is applying for funding to continue its strong commitment to advance and provide cancer prevention, control, screening, and treatment research in the community setting. Dedicated staff and a strong history of high quality and timely data, all while often exceeding accrual goals, has earned Carle the reputation that it has today. Moving forward with cancer care delivery research (CCDR), Carle's strength is a health care system that is highly integrated from top to bottom (organizationally and electronically), comprised of over 370 primary care and specialty physicians all invested in a research culture. Adding to that is a large electronically accessible insurance plan spanning multiple states and a service population that is largely rural and underserved. One previously untapped resource in the Carle community, the heavily NIH funded University of Illinois, has similar aligned interests and is pushing the Carle Cancer Center research initiatives and insight to even higher levels. One of Carle's chief initiatives is to dissect and analyze the surrounding underserved rural population in order to formulate the right questions and address the correct barriers to care. Learning the "targets" for intervention may facilitate CCDR as a whole. Carle's talented and experienced research team, based on years of experience in NCI initiated clinical trials, has rapidly acquired the skills needed to be productive and successful in cancer care delivery research. Already CCDR accrual accounts for one half of last year's total accrual. Carle Cancer Center projects an increase in cancer treatment contributions with the addition of research oriented specialty surgeons and physicians. Cancer site specialization by physicians and staff, quality initiatives, multiple multidisciplinary tumor boards, an ability to participatein imaging initiatives and bio specimen trials all attest that research treatment options will take te highest priority. Joining in our efforts will be component institutions, Rush-Copley Medical Center in Aurora, Illinois and Franciscan St. Anthony Health in Michigan City, Indiana. Both bring many years of collaborative experience and serve populations that would embrace participation in cancer care delivery research. Together, the research enterprise through the years is strong, data quality is excellent, and regulatory processes are extensive and impeccable.

描述（由申请人提供）：为了响应RFA-CA-13-013，Carle癌症中心，一个30年的传统社区临床肿瘤学项目，正在申请资金，以继续其在社区环境中推进和提供癌症预防，控制，筛查和治疗研究的坚定承诺。敬业的员工和高质量和及时的数据的强大历史，所有这些都经常超过应计目标，为Carle赢得了今天的声誉。随着癌症护理提供研究（CCDR）的发展，Carle的优势是一个从上到下（组织和电子）高度整合的医疗保健系统，由370多名初级保健和专科医生组成，他们都投资于研究文化。除此之外，还有一个跨越多个州的大型电子可访问保险计划，以及一个主要是农村和服务不足的服务人口。Carle社区中一个以前未开发的资源，即NIH资助的伊利诺伊大学，也有类似的一致利益，并将Carle癌症中心的研究计划和洞察力推向更高的水平。卡尔的主要举措之一是解剖和分析周围的服务不足的农村人口，以制定正确的问题，并解决正确的照顾障碍。了解干预的“目标”可能会促进CCDR作为一个整体。Carle的才华横溢和经验丰富的研究团队，基于NCI发起的临床试验的多年经验，迅速获得了在癌症护理提供研究中富有成效和成功所需的技能。CCDR应计费用已经占去年应计费用总额的一半。 卡尔癌症中心项目增加癌症治疗的贡献与研究导向的专业外科医生和医生的增加。医生和工作人员的癌症部位专业化、质量倡议、多学科肿瘤委员会、参与成像倡议和生物标本试验的能力都证明了研究治疗方案将获得最高优先级。 参加我们的努力将是组成机构，拉什科普利医疗中心在奥罗拉，伊利诺伊州和方济各会圣安东尼健康在密歇根市，印第安纳州。两者都带来了多年的合作经验，并为那些愿意参与癌症护理提供研究的人群提供服务。总之，多年来的研究企业是强大的，数据质量是优秀的，监管过程是广泛的和无可挑剔的。